Antibody Deficiency

Pediatric Allergy: Principles and Practice Expert Consult: Second Edition

Volumn , Issue , 2010, Pages 88-97

  Bonilla, Francisco A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28344451804     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0271-2.00008-0     Document Type: Chapter

References (80)

1. Bonilla FA, Bernstein IL, Khan DA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005, 94:S1.
2. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776.
3. Wood P, Stanworth S, Burton J, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol 2007, 149:410.
4. Rezaei N, Bonilla FA, Sullivan KE, et al. An introduction to primary immunodeficiency diseases. Primary immunodeficiency diseases: definition, diagnosis, management 2008, 1. Springer-Verlag, Berlin. N. Rezaei, A. Aghamohammadi, L. Notarangelo (Eds.).
5. Joshi AY, Iyer VN, Hagan JB, et al. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 2009, 84:16.
6. Boyle JM, Buckley RH Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007, 27:497.
7. Bruton OC Agammaglobulinemia. Pediatrics 1952, 9:722.
8. Conley ME, Broides A, Hernandez-Trujillo V, et al. Genetic analysis of patients with defects in early B cell development. Immunol Rev 2005, 203:216.
9. Bloom KA, Chung D, Cunningham-Rundles C Osteoarticular infectious complications in patients with primary immunodeficiencies. Curr Opin Rheumatol 2008, 20:480.
10. Alibrahim A, Lepore M, Lierl M, et al. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. J Allergy Clin Immunol 1998, 101:552.
11. Futatani T, Watanabe C, Baba Y, et al. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001, 114:141.
12. Kanegane H, Futatani T, Wang Y, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 2001, 108:1012.
13. Mueller OT, Hitchcock R Gene symbol: BTK. Disease: agammaglobulinaemia. Hum Genet 2008, 124:299.
14. Ferrari S, Lougaris V, Caraffi S, et al. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med 2007, 204:2047.
15. Sawada A, Takihara Y, Kim JY, et al. A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J Clin Invest 2003, 112:1707.
16. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112:277.
17. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46:1547.
18. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007, 27:308.
19. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77.
20. Cunningham-Rundles C Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008, 28(Suppl 1):S42.
21. Lopes-da-Silva S, Rizzo LV Autoimmunity in common variable immunodeficiency. J Clin Immunol 2008, 28(Suppl 1):S46.
22. Wheat WH, Cool CD, Morimoto Y, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005, 202:479.
23. Chua I, Quinti I, Grimbacher B Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol 2008, 15:368.
24. Gompels MM, Hodges E, Lock RJ, et al. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 2003, 134:314.
25. Agarwal S, Cunningham-Rundles C Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 2007, 98:185.
26. Ko J, Radigan L, Cunningham-Rundles C Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 2005, 116:37.
27. Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003, 23:385.
28. Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544.
29. Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178:3932.
30. Morra M, Silander O, Calpe S, et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001, 98:1321.
31. Weston SA, Prasad ML, Mullighan CG, et al. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?. Clin Exp Immunol 2001, 124:465.
32. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004, 113:234.
33. van Zelm MC, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901.
34. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829.
35. Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820.
36. Pan-Hammarstrom Q, Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39:429.
37. Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007, 120:1178.
38. Sekine H, Ferreira RC, Pan-Hammarstrom Q, et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 2007, 104:7193.
39. Weber-Mzell D, Kotanko P, Hauer AC, et al. Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 2004, 34:224.
40. Tahkokallio O, Seppala IJ, Sarvas H, et al. Concentrations of serum immunoglobulins and antibodies to pneumococcal capsular polysaccharides in patients with recurrent or chronic sinusitis. Ann Otol Rhinol Laryngol 2001, 110:675.
41. Koskinen S, Tolo H, Hirvonen M, et al. Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults. J Clin Immunol 1995, 15:194.
42. Cunningham-Rundles C Physiology of IgA and IgA deficiency. J Clin Immunol 2001, 21:303.
43. Aghamohammadi A, Mohammadi J, Parvaneh N, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008, 147:87.
44. Edwards E, Razvi S, Cunningham-Rundles C IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004, 111:93.
45. Kutukculer N, Karaca NE, Demircioglu O, et al. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency. Pediatr Allergy Immunol 2007, 18:167.
46. Uram R, Rosoff PM Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant. Pediatr Hematol Oncol 2003, 20:487.
47. Braconier JH Reversible total IgA deficiency associated with phenytoin treatment. Scand J Infect Dis 1999, 31:515.
48. Ferrante A, Beard LJ, Feldman RG IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Inf Dis J 1990, 9:S16.
49. Pan Q, Hammarstrom L Molecular basis of IgG subclass deficiency. Immunol Rev 2000, 178:99.
50. Olinder-Nielsen AM, Granert C, Forsberg P, et al. Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up. Scand J Infect Dis 2007, 39:44.
51. Bartmann P, Grosch-Worner I, Wahn V, et al. IgG2 deficiency in children with human immunodeficiency virus infection. Eur J Pediatr 1991, 150:234.
52. Aucouturier P, Bremard-Oury C, Griscelli C, et al. Serum IgG subclass deficiency in ataxia telangiectasia. Clin Exp Immunol 1987, 68:392.
53. Kristinsson VH, Kristinsson JR, Jonmundsson GK, et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol 2001, 18:167.
54. Boyle RJ, Le C, Balloch A, et al. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol 2006, 146:486.
55. Javier FC, Moore CM, Sorensen RU Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol 2000, 84:25.
56. Dorsey MJ, Orange JS Impaired specific antibody response and increased B cell population in transient hypogammaglobulinemia of infancy. Ann Allergy Asthma Immunol 2006, 97:590.
57. Inaba H, Hori H, Ito M, et al. Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia. Scand J Infect Dis 2001, 33:630.
58. Lougaris V, Badolato R, Ferrari S, et al. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005, 203:48.
59. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003, 82:373.
60. Bonilla FA, Geha RS CD154 deficiency and related syndromes. Immunol Allergy Clin North Am 2001, 21:65.
61. Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001, 98:12614.
62. Durandy A, Taubenheim N, Peron S, et al. Pathophysiology of B cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol 2007, 94:275.
63. Agarwal S, Cunningham-Rundles C Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol 2007, 99:281.
64. Hare ND, Smith BJ, Ballas ZK Antibody response to pneumococcal vaccination as a function of preimmunization titer. J Allergy Clin Immunol 2009, 123:195.
65. Paris K, Sorensen RU Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 2007, 99:462.
66. Leinonen M, Sakkinen A, Kalliokoski R, et al. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986, 5:39.
67. Conley ME, Rohrer J, Minegishi Y X-linked agammaglobulinemia. Clin Rev Allergy Immunol 2000, 19:183.
68. De Diego JI, Prim MP, Alfonso C, et al. Comparison of amoxicillin and azithromycin in the prevention of recurrent acute otitis media. Int J Pediatr Otorhinolaryngol 2001, 58:47.
69. Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006, 117:S525.
70. Eijkhout HW, van Der Meer JW, Kallenberg CG, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: a randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001, 135:165.
71. Berger M Subcutaneous administration of IgG. Immunol Allergy Clin North Am 2008, 28:779.
72. Quartier P, Debre M, De Blic J, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999, 134:589.
73. Busse PJ, Razvi S, Cunningham-Rundles C Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001.
74. Horn J, Thon V, Bartonkova D, et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 2007, 122:156.
75. Sundin U, Nava S, Hammarstrom L Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 1998, 112:341.
76. Ahrens N, Hoflich C, Bombard S, et al. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment. Clin Exp Immunol 2008, 151:455.
77. Barlan IB, Geha RS, Schneider LC Therapy for patients with recurrent infections and low serum IgG3 levels. J Allergy Clin Immunol 1993, 92:353.
78. Chapel HM, Spickett GP, Ericson D, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol 2000, 20:94.
79. Dalal I, Reid B, Nisbet-Brown E, et al. The outcome of patients with hypogammaglobulinemia in infancy and early childhood. J Pediatr 1998, 133:144.
80. Moschese V, Graziani S, Avanzini MA, et al. A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol 2008, 21:343.